Realcan Pharmaceutical Group Co., Ltd.
SZSE:002589.SZ
3.35 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 7,966.346 | 8,034.368 | 12,311.278 | 21,059.719 | 27,203.884 | 35,258.509 | 33,918.534 | 23,293.62 | 15,618.666 | 9,749.958 | 7,785.907 | 5,925.842 | 4,622.238 | 3,195.448 | 2,213.383 | 1,601.731 | 1,147.11 |
| Kosten van de omzet
| 7,090.143 | 7,212.307 | 10,639.203 | 17,220.742 | 22,227.122 | 28,439.371 | 27,424.648 | 18,997.993 | 13,171.388 | 8,680.343 | 7,080.523 | 5,416.68 | 4,245.329 | 2,933.685 | 2,029.63 | 1,464.093 | 1,045.467 |
| Brutowinst
| 876.203 | 822.061 | 1,672.075 | 3,838.977 | 4,976.762 | 6,819.138 | 6,493.886 | 4,295.628 | 2,447.278 | 1,069.615 | 705.384 | 509.162 | 376.909 | 261.763 | 183.753 | 137.638 | 101.643 |
| Brutowinstmarge
| 0.11 | 0.102 | 0.136 | 0.182 | 0.183 | 0.193 | 0.191 | 0.184 | 0.157 | 0.11 | 0.091 | 0.086 | 0.082 | 0.082 | 0.083 | 0.086 | 0.089 |
| Onderzoek- en ontwikkelingskosten
| 10.029 | 39.542 | 22.678 | 11.563 | 8.914 | 6.971 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 144.697 | 172.735 | 304.69 | 428.135 | 534.316 | 663.145 | 705.004 | 469.752 | 209.408 | 107.132 | 41.285 | 26.597 | 24.545 | 22.332 | 17.074 | 15.194 | 11.596 |
| Verkoop- en marketingkosten
| 204.634 | 260.663 | 847.149 | 1,742.779 | 2,174.907 | 2,649.176 | 2,164.518 | 1,505.229 | 931.974 | 408.616 | 234.026 | 136.892 | 95.923 | 63.426 | 39.736 | 28.996 | 22.376 |
| Verkoop-, algemene en administratieve kosten
| 349.331 | 846.002 | 1,151.839 | 2,170.913 | 2,709.223 | 3,312.321 | 2,869.521 | 1,974.981 | 1,141.382 | 515.748 | 275.311 | 163.489 | 120.467 | 85.758 | 56.81 | 44.19 | 33.972 |
| Overige kosten
| 491.31 | 63.152 | 430.448 | 621.505 | 662.241 | 904.925 | 780.739 | 415.303 | 16.871 | 9.547 | 6.02 | -1.261 | 32.985 | -1.028 | 16.797 | 12.033 | 12.029 |
| Bedrijfskosten
| 850.67 | 948.697 | 1,604.964 | 2,803.981 | 3,380.378 | 4,224.217 | 3,650.26 | 2,390.285 | 1,414.289 | 648.994 | 378.904 | 236.227 | 167.205 | 116.018 | 76.725 | 58.809 | 46.852 |
| Bedrijfsresultaat
| 25.533 | -126.635 | 67.111 | 1,300.24 | 1,704.072 | 2,537.597 | 2,701.461 | 1,810.272 | 861.345 | 308.941 | 235.769 | 195.306 | 151.942 | 113.555 | 85.141 | 62.889 | 39.642 |
| Bedrijfsresultaat ratio
| 0.003 | -0.016 | 0.005 | 0.062 | 0.063 | 0.072 | 0.08 | 0.078 | 0.055 | 0.032 | 0.03 | 0.033 | 0.033 | 0.036 | 0.038 | 0.039 | 0.035 |
| Totaal overige inkomsten en kosten netto
| 16.036 | -8.782 | -27.292 | -835.222 | -787.774 | -2,435.222 | -749.206 | 0.102 | -95.057 | 9.515 | 5.99 | -1.804 | -41.037 | -25.722 | -20.639 | -12.382 | -8.115 |
| Inkomen voor belasting
| 41.569 | -135.418 | -1,743.912 | 465.018 | 915.479 | 102.376 | 1,962.634 | 1,810.375 | 878.069 | 318.456 | 241.759 | 193.502 | 147.841 | 112.437 | 83.176 | 60.09 | 38.471 |
| Inkomen voor belasting ratio
| 0.005 | -0.017 | -0.142 | 0.022 | 0.034 | 0.003 | 0.058 | 0.078 | 0.056 | 0.033 | 0.031 | 0.033 | 0.032 | 0.035 | 0.038 | 0.038 | 0.034 |
| Belastingkosten
| 0.551 | -167.389 | -4.439 | 83.005 | 290.927 | 537.356 | 684.828 | 441.919 | 202.995 | 75.323 | 59.998 | 49.26 | 37.172 | 28.414 | 21.044 | 15.28 | 9.293 |
| Nettowinst
| 20.622 | 20.318 | -1,739.473 | 382.013 | 624.552 | -434.98 | 1,277.806 | 1,368.456 | 590.759 | 235.939 | 180.987 | 143.555 | 110.651 | 84.057 | 62.109 | 44.757 | 29.178 |
| Nettowinstmarge
| 0.003 | 0.003 | -0.141 | 0.018 | 0.023 | -0.012 | 0.038 | 0.059 | 0.038 | 0.024 | 0.023 | 0.024 | 0.024 | 0.026 | 0.028 | 0.028 | 0.025 |
| WPA (Winst Per Aandeel)
| 0.014 | 0.014 | -1.18 | 0.26 | 0.42 | -0.29 | 0.86 | 0.91 | 0.44 | 0.19 | 0.18 | 0.16 | 0.13 | 0.11 | 0.097 | 0.077 | 0.06 |
| Verwaterde WPA
| 0.014 | 0.014 | -1.18 | 0.26 | 0.42 | -0.29 | 0.86 | 0.91 | 0.44 | 0.19 | 0.18 | 0.16 | 0.13 | 0.11 | 0.097 | 0.077 | 0.06 |
| EBITDA
| 472.518 | 439.434 | -960.815 | 1,338.651 | 1,797.826 | 1,378.727 | 2,981.563 | 2,019.115 | 1,061.996 | 449.828 | 343.904 | 273.973 | 194.391 | 142.421 | 101.957 | 73.894 | 48.538 |
| EBITDA ratio
| 0.059 | 0.055 | -0.078 | 0.064 | 0.066 | 0.039 | 0.088 | 0.087 | 0.068 | 0.046 | 0.044 | 0.046 | 0.042 | 0.045 | 0.046 | 0.046 | 0.042 |